Jefferies analyst Kelechi Chikere reiterated a Buy rating and $310.00 price target on Novavax (NASDAQ: NVAX) after speaking wtih management ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE